HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bing Zhou Selected Research

Ossifying Fibroma

10/2010[Resection of the ossifying fibroma of paranasal sinuses and anterior skull base with nasal endoscope under the guidance of image navigation].
12/2003[Surgery of ossifying fibroma of the sinuses].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bing Zhou Research Topics

Disease

60Neoplasms (Cancer)
04/2024 - 12/2005
23Inflammation (Inflammations)
09/2023 - 05/2004
20Rhinosinusitis
10/2023 - 09/2007
16Allergic Rhinitis
12/2023 - 04/2003
13Nasal Polyps (Nasal Polyp)
10/2023 - 05/2003
11Infections
05/2024 - 07/2008
11Non-alcoholic Fatty Liver Disease
01/2024 - 07/2017
10Neoplasm Metastasis (Metastasis)
01/2023 - 01/2014
9Carcinogenesis
03/2024 - 02/2014
8Breast Neoplasms (Breast Cancer)
03/2024 - 01/2012
8Leukemia
03/2024 - 04/2012
8COVID-19
12/2022 - 01/2020
7Fatty Liver
12/2023 - 12/2014
6Malaria
12/2023 - 03/2010
6Fibrosis (Cirrhosis)
01/2022 - 01/2017
6Hypersensitivity (Allergy)
01/2021 - 06/2002
5Insulin Resistance
01/2024 - 01/2017
5Asthma (Bronchial Asthma)
10/2023 - 05/2004
5Rheumatoid Arthritis
10/2022 - 03/2014
5Alzheimer Disease (Alzheimer's Disease)
10/2022 - 01/2012
5Sinusitis
09/2022 - 05/2004
4Adenocarcinoma of Lung
01/2023 - 01/2020
4Hypertension (High Blood Pressure)
10/2022 - 11/2016
4Body Weight (Weight, Body)
01/2022 - 01/2013
4Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2021 - 08/2020
4Neurodegenerative Diseases (Neurodegenerative Disease)
05/2021 - 09/2013
4Wounds and Injuries (Trauma)
05/2019 - 05/2017
4Pancreatitis
03/2013 - 04/2009
3Atrial Fibrillation
11/2023 - 10/2016
3Osteosarcoma (Osteogenic Sarcoma)
01/2023 - 09/2019
3Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 05/2005
3Adenoma (Adenomas)
01/2022 - 04/2012
3Alcoholic Fatty Liver
01/2022 - 12/2014
3Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)
01/2022 - 01/2003
3Atherosclerosis
01/2022 - 10/2010
3Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 01/2016
3Ischemic Stroke
12/2021 - 01/2019
3Parkinson Disease (Parkinson's Disease)
11/2021 - 03/2014
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2021 - 01/2018
3Hypoxia (Hypoxemia)
05/2021 - 08/2009
3Carcinoma (Carcinomatosis)
01/2021 - 01/2012
3Obesity
11/2020 - 01/2019
3Eosinophilia
08/2013 - 02/2004

Drug/Important Bio-Agent (IBA)

36Proteins (Proteins, Gene)FDA Link
01/2023 - 05/2003
10Messenger RNA (mRNA)IBA
03/2024 - 11/2004
9CytokinesIBA
06/2023 - 08/2003
8EnzymesIBA
03/2024 - 12/2003
8Glucose (Dextrose)FDA LinkGeneric
01/2024 - 08/2002
8SteroidsIBA
10/2023 - 11/2004
8MicroRNAs (MicroRNA)IBA
12/2021 - 08/2014
7IronIBA
01/2024 - 01/2003
7Therapeutic UsesIBA
01/2023 - 12/2005
7Long Noncoding RNAIBA
01/2023 - 01/2014
6AntibodiesIBA
05/2024 - 07/2014
6Biomarkers (Surrogate Marker)IBA
01/2024 - 08/2017
6Immunoglobulin E (IgE)IBA
01/2021 - 06/2002
6Interleukin-5 (Interleukin 5)IBA
06/2009 - 08/2003
5snake venom protein C activatorIBA
03/2024 - 08/2018
5RNA (Ribonucleic Acid)IBA
01/2024 - 01/2019
5Neutralizing AntibodiesIBA
01/2022 - 07/2014
5Triglycerides (Triacylglycerol)IBA
01/2022 - 05/2005
5ZincIBA
12/2016 - 07/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2014 - 12/2003
4AntigensIBA
05/2024 - 04/2000
4LipopolysaccharidesIBA
01/2022 - 01/2013
4DNA (Deoxyribonucleic Acid)IBA
12/2021 - 05/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 09/2005
4CateninsIBA
09/2019 - 01/2013
4artemisinin (artemisinine)IBA
01/2017 - 03/2010
4CeruletideIBA
03/2013 - 04/2009
3Transcription Factors (Transcription Factor)IBA
03/2024 - 08/2003
3AntioxidantsIBA
01/2023 - 01/2017
36-methyladenineIBA
01/2023 - 01/2021
3C-Reactive ProteinIBA
01/2023 - 12/2020
3CopperIBA
10/2022 - 09/2013
3Angiotensin IIIBA
10/2022 - 09/2016
3Indicators and Reagents (Reagents)IBA
01/2022 - 01/2014
3LipidsIBA
01/2022 - 06/2005
3Monoclonal AntibodiesIBA
01/2022 - 01/2020
3MethyltransferasesIBA
12/2021 - 01/2019
3Cadherins (E-Cadherin)IBA
12/2021 - 07/2011
3Circular RNAIBA
12/2021 - 10/2017
3MetalsIBA
11/2021 - 06/2007
3Matrix Metalloproteinases (MMPs)IBA
12/2015 - 08/2002
3Interleukin-12 (IL 12)IBA
06/2009 - 06/2005
3AllergensIBA
06/2006 - 03/2005
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2004 - 04/2003
2Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
03/2024 - 10/2022
2Fluticasone (Cutivate)FDA LinkGeneric
12/2023 - 09/2023
2Nasal SpraysIBA
12/2023 - 09/2023
2azelastine (Optivar)FDA LinkGeneric
12/2023 - 09/2023
2N-methyladenosineIBA
10/2023 - 01/2021
2FructoseIBA
09/2023 - 01/2021

Therapy/Procedure

33Therapeutics
11/2023 - 06/2006
5Stents
10/2023 - 06/2015
4Immunotherapy
08/2022 - 03/2008
4Drug Therapy (Chemotherapy)
01/2022 - 02/2014
4Operative Surgical Procedures
08/2021 - 12/2003
4Endoscopes
10/2013 - 08/2005
3Radiotherapy
11/2021 - 06/2019